Butyricimonas phoceensis

Bacteria
General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview

  • Butyricimonas phoceensis is a Gram-negative, non-spore-forming, anaerobic, motile, rod-shaped bacterium. It has been detected in at least 1 gut microbiome compilation study or metastudy. The DNA G+C content is 42.5%. Butyricimonas phoceensis is probably a rare gut coloniser. (Togo2016)



  • This organism has been recovered from human faeces (Togo2016). Pathogenicity status unknown, or very unlikely to be pathogenic. A possible gut commensal.
    • GENERAL CHARACTERISTICS (Togo2016);
    Character Response
  • 🧂
  • Salt tolerance:
  • tolerates 5% salt; doesn't tolerate 10% salt;
  • 🌡
  • Temperature tolerance:
  • grows at 28℃; grows at 37℃; Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • glucose; mannose; lactose; glycerol;
  • ⥅
  • Substrates assimilated or utilised:
  • glucose; mannose; citrate; 2-ketogluconate;
  • Active enzymes:
  • alkaline phosphatase; acid phosphatase; N-Ac β-glucosaminidase; catalase; esterase C4; esterase lipase C8; β-galactosidase; naphthol-ASBI-P;
    • SPECIAL FEATURES (Togo2016);
    Character Response
  • ✓
  • Metabolites produced:
  • indole;
    • RESPONSE TO ANTIBIOTICS (Togo2016);
    Class Active Resistant
  • Penicillins:
  • amoxicillin; amoxicillin-clavulanic acid; doripenem; imipenem; penicillin G;
  • oxacillin;
  • Macrolides:
  • erythromycin;
  • Tetracyclines:
  • doxycycline;
  • Quinolines:
  • ciprofloxacin;
  • Aminoglycosides:
  • gentamicin-500;
  • gentamicin;
  • Polypep/ketides:
  • rifampicin;
  • Heterocycles:
  • metronidazole; sulfamethoxazole; trimethoprim;
  • fosfomycin;
  • Vancomycins:
  • vancomycin; teicoplanin;
  • Miscellaneous antibiotics:
  • clindamycin;
  • colistin;

    • Details

    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Bacteroidetes Class:  Bacteroidia Order:  Bacteroidales Family:  Odoribacteraceae Genus:  Butyricimonas Gram stain:  neg O2 Relation.:  anaerobic Spore:  No spore Motility:  Swimming Morphology:  Rod
    Health:  Unknown
    Source:  human faeces (Togo2016)
    DNA G+C(%):  42.5
    Opt. T:  37℃
    Lower T(℃):  28(+)
    Mid T(℃):  37(+)
    NaCl 3-5%:  5(+)
    NaCl >6%:  10(neg)
    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    Glucose:  + Mannose:  + Lactose:  + Glycerol:  +
    SUBSTRATE ASSIMILATION & UTILISATION
    Monosaccharide util/assim Oligosaccharide util/assim Other carboh. util/assim Amino acid util/assim Organic acid util/assim
    L-Arabinose:  neg Glucose:  + Mannose:  + Maltose:  neg Mannitol:  neg Citrate:  + 2-Ketogluconate:  +
    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Oxidase:  neg Catalase:  + Urease:  neg Ac-β-glcamnd:  + β-Galactosidase:  + AlkalineP:  + AcidP:  + Esterase(C4):  + EstLip(C8):  +
    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    		Indole:  +
    ANTIBIOTICS ℞
    Penicillins & Penems (μg/mL) Cephalosporins (μg/mL) Aminoglycosides (μg/mL) Macrolides (μg/mL) Quinolones (μg/mL)
    amoxicillin:  S(25; disc)
    Augmentin:  S(30; disc)
    oxacillin:  R(5)
    penicillin_G:  S(10U)
    doripenem:  S(10; disc)
    imipenem:  S(10)
    gentamicin:  R(15)
    gentamicin-500:  S(500; disc)
    erythromycin:  R(15U)
    ciprofloxacin:  R(5)
    Tetracyclines (μg/mL) Vancomycin Class (μg/mL) Polypep/ketides (μg/mL) Heterocycles (μg/mL) Other (μg/mL)
    doxycycline:  S(30U)
    teicoplanin:  S(30; disc)
    vancomycin:  S(30; disc)
    rifampicin:  S(30; disc)
    fosfomycin:  R(10)
    metronidazole:  S(4; disc)
    sulfamethoxazole:  S(25; disc)
    trimethoprim:  S(1.25)
    clindamycin:  S(15; disc)
    colistin:  R(CT50)

    References

    SPECIFIC REFERENCES FOR BUTYRICIMONAS PHOCEENSIS
  • Togo2016 - Butyricimonas phoceensis sp. nov., a new anaerobic species isolated from the human gut microbiota of a French morbidly obese patient.
  • ...............................
    • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR BUTYRICIMONAS PHOCEENSIS
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • ...............................
    • Added: September 07, 2021